On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Epidemiology and Risk Factors
-
41 min
1. The changing prevalence of asthma- Dr. Deborah Jarvis
-
29 min
2. Recent advances in asthma genetics- Prof. Miriam Moffatt
-
35 min
3. Asthma: an epidemic caused by epigenetics?- Prof. David Schwartz
-
30 min
4. Role of the microbiota in asthma- Prof. B. Brett Finlay
-
32 min
5. Diet and asthma- Prof. Lewis Smith
-
43 min
6. Obesity and asthma- Prof. Anne Dixon
-
35 min
7. Occupational asthma: management beyond the textbooks- Prof. Paul Cullinan
- Clinical Phenotypes
-
42 min
8. The origins of asthma- Prof. Peter Sly
-
46 min
9. Pre-school wheeze- Prof. Andrew Bush
-
50 min
-
24 min
11. Smoking asthmatics- Prof. Neil Thomson
-
27 min
12. Aspirin exacerbated respiratory disease- Prof. Chris Corrigan
- Mechanisms of Asthma
-
48 min
13. Advances in asthma: airway inflammation- Prof. William Busse
-
48 min
14. The role of mast cells in asthma- Prof. Peter Bradding
-
67 min
15. Dendritic cells in asthma- Prof. Bart Lambrecht
-
30 min
16. The airway smooth muscle in asthma- Prof. Judith Black
-
49 min
17. Role of virus infection in asthma 1- Prof. Sebastian Johnston
-
27 min
18. Role of virus infection in asthma 2- Prof. Sebastian Johnston
-
51 min
19. Severe asthma: characterisation, mechanisms & treatment- Prof. Fan Chung
-
46 min
20. Steroid resistance in asthma: mechanisms and potential therapies- Prof. Ian Adcock
-
26 min
21. Macrophage in asthma- Prof. Douglas Robinson
- Diagnosis of Asthma
-
70 min
22. Physiology of asthma and involvement of small airways- Prof. Charles G. Irvin
-
27 min
23. Induced sputum in asthma- Prof. Antonio Spanevello
-
61 min
- Therapy and Management
-
41 min
25. Pulmonary drug delivery- Prof. Anthony J. Hickey
-
32 min
26. The management of chronic asthma- Prof. Mark Fitzgerald
-
21 min
27. Inhaled corticosteroids and beta2-agonists- Dr. Omar S. Usmani
-
20 min
28. Management of "difficult asthma"- Prof. Elisabeth Bel
-
47 min
29. Management of acute exacerbations of asthma- Dr. Chris Fanta
-
34 min
30. Non-pharmacological treatments for asthma- Prof. Neil Thomson
-
45 min
31. Asthma: beyond the prescription- Prof. Martyn Partridge
-
45 min
32. New drugs for asthma- Prof. Peter Barnes
-
24 min
33. Anti-IgE therapy for asthma- Dr. Andrew Menzies-Gow
- Archived Lectures *These may not cover the latest advances in the field
-
45 min
34. New drugs for asthma- Prof. Peter Barnes
-
35 min
35. Asthma phenotypes in children- Prof. Andrew Bush
-
40 min
36. Steroid resistance in asthma: mechanisms and potential therapies- Prof. Ian Adcock
-
42 min
37. Severe asthma in children- Prof. Andrew Bush
Printable Handouts
Navigable Slide Index
- Introduction
- The need for new asthma treatments
- Poor asthma control in the real world
- Asthma deaths and therapy (UK)
- Managing mild asthma: SYGMA 1
- Managing mild asthma: SYGMA 2
- NOVEL-START study
- GINA
- Severe asthma
- Severe asthma: inflammatory phenotypes
- Unmet needs in asthma therapy
- Targeting T2 (eosinophilic) inflammation
- Interleukin-5 in asthma
- Anti-IL-5 and asthma exacerbations
- Benralizumab in severe asthma
- Interleukin-4/13 in asthma
- Dupilumab: severe asthma
- Dupilumab in asthma
- GATA-3 inhibition
- TSLP and asthma
- Anti-TSLP: severe asthma
- IL-33 and asthma
- DP2 antagonists in asthma
- Fevipiprant in severe asthma
- Targeting neutrophil inflammation
- Anti-TNF in severe asthma
- CXCR2 antagonist in severe asthma
- IL-17 expression in asthma
- Anti-IL-17R in asthma
- Macrolide in severe asthma
- New anti-inflammatory treatments
- PDE4 inhibitors
- Roflumilast in asthma
- Tiotropium in poorly controlled asthma
- Mast cell inhibitors
- Masitinib in severe asthma
- A cure for asthma?
- Conclusions: new asthma treatments
Topics Covered
- Improvements in existing therapies have been the main approach
- New classes of drug in development
- Upcoming oral and inhaled therapies that target inflammation in asthma
- Patients with severe disease
- Inflammation in severe asthma is usually corticosteroid insensitive
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Barnes, P. (2011, December 29). New drugs for asthma [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 19, 2025, from https://doi.org/10.69645/KLFN8478.Export Citation (RIS)
Publication History
Financial Disclosures
- Peter Barnes receives research grants from AstraZeneca and Boehringer-Ingelheim and is an advisor and/or gives talks for AstraZeneca, Boehringer-Ingelheim, Covis, Novartis, Pieris and Teva.
